| scholarly article | Q13442814 |
| P50 | author | Vivekanand Jha | Q38800410 |
| P2093 | author name string | Vinay Sakhuja | |
| Harbir S Kohli | |||
| Kamal Sud | |||
| Krishan L Gupta | |||
| A N Aravindan | |||
| Machiraju S Ravi Shankar | |||
| Preet M Sohal | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| tuberculin | Q29505 | ||
| P304 | page(s) | 2720-2724 | |
| P577 | publication date | 2005-09-27 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis | |
| P478 | volume | 20 |
| Q38541022 | A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection |
| Q38858669 | A retrospective review of the two-step tuberculin skin test in dialysis patients |
| Q35547610 | Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study |
| Q40341751 | Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients |
| Q41667766 | Feasibility of the interferon-gamma enzyme-linked immunospot assay in chronic renal failure patients and immunocompetent subjects: a head-to-head comparison |
| Q26740463 | Hemodialysis in Asia |
| Q34075496 | High prevalence of latent tuberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test |
| Q83179093 | High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test |
| Q44836771 | Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region |
| Q44784238 | Interferon Gamma Release Assays to Diagnose Latent Tuberculosis Infection in Pediatric Dialysis Patients |
| Q44701835 | Managing latent tuberculosis in UK renal transplant units: how does practice compare with published guidance? |
| Q42923729 | Mycobacterium tuberculosis infection following kidney transplantation |
| Q30997529 | Patterns of uveitis at the Apex Institute for Eye Care in India: Results from a prospectively enrolled patient data base (2011-2013). |
| Q33823947 | Prevalence of latent tuberculosis infection and risk of infection in patients with chronic kidney disease undergoing hemodialysis in a referral center in Brazil. |
| Q37088882 | Preventive health care in chronic kidney disease and end-stage renal disease |
| Q35782733 | Serial interferon-gamma release assays for latent tuberculosis in dialysis patients with end stage renal disease in a Korean population |
| Q56791397 | Tubercular Uveitis |
| Q84960387 | Tuberculin Skin Test, Interferon-gamma Assay, and T Cells Subpopulations in Hemodialysis Patients |
| Q53432230 | Tuberculin reaction is not attenuated in patients with rheumatoid arthritis living in a region with intermediate burden of tuberculosis. |
| Q42392642 | Tuberculin skin test for the diagnosis of latent tuberculosis during renal replacement therapy in an endemic area: A single center study. |
| Q37150892 | Tuberculosis in haemodialysis patients: A single centre experience |
| Q34385468 | Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis. |
| Q80212349 | What is the best way of screening hemodialysis patients for latent tuberculosis? |
Search more.